spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  natriuretic peptide 

 HSMN NewsFeed - 29 May 2024
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Devices Diagnostics Cardiology FDA
 HSMN NewsFeed - 21 Feb 2022
Abbott's CardioMEMS(TM) HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 19 Nov 2021
BioMarin Receives FDA Approval for VOXZOGO(TM) (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Aug 2021
European Commission Approves BioMarin's VOXZOGO(R) (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jun 2021
Palatin Announces New Additions to Its Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2021
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Aug 2020
BioMarin Submits New Drug Application to U.S. Food and Drug Administration for Vosoritide to Treat Children with Achondroplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jul 2019
Ortho Receives CE Mark for Enhanced VITROS(R) Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 8 Aug 2018
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2018
Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor
Devices Monitoring Cardiology
 HSMN NewsFeed - 17 Feb 2017
Capricor Therapeutics Provides Update on Natriuretic Peptide Program
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2017
Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda(TM)
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 11 Dec 2015
Cardiorentis' Ularitide Receives FDA Fast Track Designation for the Treatment of Acute Decompensated Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Oct 2014
Capricor Therapeutics Announces Acquisition of Intellectual Property Rights to Family of Natriuretic Peptides From Medtronic, Inc.
Biopharmaceuticals Devices Cardiology Acquisitions
 HSMN NewsFeed - 15 May 2014
Sorbent Therapeutics Closes First Tranche Of $15 Million Series D Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 13 Jan 2014
BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2013
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Oct 2012
Bayer's Investigational Riociguat Meets Primary Endpoint in Phase III Study in Patients with Pulmonary Arterial Hypertension (PAH)
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2011
Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Feb 2011
Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Nov 2010
Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2009
Nile Therapeutics Appoints Frank Litvack, M.D., to Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 8 May 2008
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
Biopharmaceuticals Acquisitions Cardiology
 HSMN NewsFeed - 5 Nov 2007
Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Oct 2007
bioMerieux Launches VIDAS(R) NT-proBNP, an Aid for Diagnosis and Prognosis of Heart Failure
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 21 Sep 2007
Nile Therapeutics, Inc. Adds to Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Diagnostics Licensing
 HSMN NewsFeed - 19 Jun 2007
New Study Demonstrates Significant Economic and Clinical Value of NT-proBNP Testing for the Management of Heart Failure
Diagnostics Cardiology
 HSMN NewsFeed - 31 May 2007
Peter M. Strumph Named CEO of Nile Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2007
Beckman Coulter and Biosite Amend Definitive Acquisition Agreement
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 25 Mar 2007
Beckman Coulter to Acquire Biosite Incorporated
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 5 Mar 2007
A Major Study Compares Direct Blood Volume Measurement Using the BVA-100 With the BNP Test for Managing Fluid Therapy in the Intensive Care Unit
Devices
 HSMN NewsFeed - 3 Jan 2007
CoGenesys Files to Begin Clinical Trials of Neugranin for the Prevention of Infections in Cancer Patients
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Response Biomedical Files for US FDA 510k Market Clearance of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
Diagnostics Cardiology FDA
 HSMN NewsFeed - 19 Sep 2006
Benefits of Vasomedical's EECP Therapy in Heart Failure Presented at the 10th Annual HFSA Scientific Meeting
Devices Cardiology
 HSMN NewsFeed - 14 Sep 2006
Medivation Appoints Dr. Andrew A. Protter Vice President of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2006
CoGenesys Receives FDA Clearance to Commence Clinical Trials of Cardeva in Patients with Chronic Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 15 May 2006
Response Biomedical and Shionogi Finalize Commercialization Agreement For RAMP Cardiovascular Testing in Japan
Diagnostics Cardiology
Return to NewsFeed  

 Additional items found! 42

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 42 additional stories matching:
natriuretic peptide
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.